Stay updated on Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.

Latest updates to the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, indicating a maintenance release. No substantive content changes are present.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page shows revision v3.6.4 replacing v3.6.3, indicating a small, administrative update to the page.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2; this indicates a small update to the page template rather than changes to the study information.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now shows Revision: v3.6.2 replacing v3.6.0, indicating a newer page revision. This is a metadata update and does not alter the study content, eligibility criteria, or listed locations.SummaryDifference0.0%

- Check67 days agoChange DetectedNew sections and label refinements have been added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and a reformatted Intervention/Treatment label. The revision note was updated from v3.5.5 to v3.6.0, and the recruitment status now shows No longer looking for participants, indicating enrollment is closed.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing v3.5.4. It indicates a minor page version update with no apparent changes to the study details or related information.SummaryDifference0.0%

Stay in the know with updates to Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.